PLASMAPHERESIS
By
Dr.Mohamed Abd El Gawad
Nephrology Specialist at New Mansoura
General Hospital
Agenda
 What is Plasmapheresis ?
 INDICATIONS FOR PLASMAPHERESIS
TECHNIQUES
Replacement fluid
Vascular access
Anticoagulation
Regimens of PE
Complications
What is Plasmapheresis ?
INDICATIONS FOR PLASMAPHERESIS
TECHNIQUES
A: Centrifugal plasma separation : blood cells
are separated during centrifugation , there
are two centrifugation methods Intermittent
flow device and continuous flow device
B: membrane plasma separation : plasma
separators use membranes with a molecular
weight 3 million
membrane plasma separation
 Uses highly permeable hollow fibers with membrane pores
of 0.2to 0.5 µm.
 The hollow fiber functions as a membrane, with the pore
size (0.2to 0.5 µm) allowing transport of plasma across the
membrane while retaining other blood components.
 PlasmaFlux filters contain the polysulfone-based
Plasmasulfone membrane, which has been designed to
minimise the activation of the patient’s immune system
during blood–membrane interaction
Plasma volume
Plasma volume =
( 0.07 × Body Weight ) × ( 1 - Hct )
( 0.07 × 70 ) × ( 1 - .4 )
= 2.9 L
Serum Albumin
Serum Albumin : 4 g /dL
40 g /L
40 × 3 = 120 g /3L
Electrolytes
Calcium:
10 ml of calcium gluconate solution per liter of
replacement solution
Potassium :
4 mmol of Potassium to each liter of
replacement solution
Vascular access
Standard central venous catheters
 Arteriovenous(AV) fistula
 Peripheral access through large-bore, short,
intravenous cannulae
Anticoagulation
1 - Citrate
 IT is used for centrifugal plasma exchang.
 citrate has particular advantages in patients at higher
bleeding risk in view of its lack of systemic anticoagulant
actions.
 Citrate is rapidly metabolized by the liver (normal levels
within 4 hours).
Hepatic dysfunction ⇒ severe hypocalcemia
2 – Heparin
 Used for membrane plasma filtration
 Higher doses may be needed than in hemodialysis as a
result of increased losses during the procedure (heparin
is protein bound).
 Bolus doses of unfractionated heparin 2000 to 5000 U
are given initially, and then 500 to 2000 U/h.
Regimens of PE?
Volume of
exchange
1-1.5 plasma
volume
Frequency of
procedures
Duration of
therapy
Frequancy of procedures
1- Daily plasma exchange
 Most effective in rapidly depleting total body load.
 Intensity of exchanges has no major effect on
outcomes except in hemolytic-uremic syndrome.
2- Alternate-day exchanges
 proven efficacy in antineutrophil cytoplasmic
antibody (ANCA)–associated diseases.
 A single plasma volume exchange will lower
plasma macromolecule levels by
approximately 60% .
 Five exchanges during 5 to 10 days will clear
90% of the total body Immunoglobulin
Target molecule kinetics during therapeutic plasma exchange.
Mark E. Williams, and Rasheed A. Balogun CJASN
doi:10.2215/CJN.04680513
©2013 by American Society of Nephrology
THANK YOU

Plasmapheresis.

  • 1.
    PLASMAPHERESIS By Dr.Mohamed Abd ElGawad Nephrology Specialist at New Mansoura General Hospital
  • 2.
    Agenda  What isPlasmapheresis ?  INDICATIONS FOR PLASMAPHERESIS TECHNIQUES Replacement fluid Vascular access Anticoagulation Regimens of PE Complications
  • 3.
  • 5.
  • 10.
    TECHNIQUES A: Centrifugal plasmaseparation : blood cells are separated during centrifugation , there are two centrifugation methods Intermittent flow device and continuous flow device B: membrane plasma separation : plasma separators use membranes with a molecular weight 3 million
  • 14.
    membrane plasma separation Uses highly permeable hollow fibers with membrane pores of 0.2to 0.5 µm.  The hollow fiber functions as a membrane, with the pore size (0.2to 0.5 µm) allowing transport of plasma across the membrane while retaining other blood components.  PlasmaFlux filters contain the polysulfone-based Plasmasulfone membrane, which has been designed to minimise the activation of the patient’s immune system during blood–membrane interaction
  • 15.
    Plasma volume Plasma volume= ( 0.07 × Body Weight ) × ( 1 - Hct ) ( 0.07 × 70 ) × ( 1 - .4 ) = 2.9 L
  • 18.
    Serum Albumin Serum Albumin: 4 g /dL 40 g /L 40 × 3 = 120 g /3L
  • 19.
    Electrolytes Calcium: 10 ml ofcalcium gluconate solution per liter of replacement solution Potassium : 4 mmol of Potassium to each liter of replacement solution
  • 20.
    Vascular access Standard centralvenous catheters  Arteriovenous(AV) fistula  Peripheral access through large-bore, short, intravenous cannulae
  • 21.
    Anticoagulation 1 - Citrate IT is used for centrifugal plasma exchang.  citrate has particular advantages in patients at higher bleeding risk in view of its lack of systemic anticoagulant actions.  Citrate is rapidly metabolized by the liver (normal levels within 4 hours). Hepatic dysfunction ⇒ severe hypocalcemia
  • 22.
    2 – Heparin Used for membrane plasma filtration  Higher doses may be needed than in hemodialysis as a result of increased losses during the procedure (heparin is protein bound).  Bolus doses of unfractionated heparin 2000 to 5000 U are given initially, and then 500 to 2000 U/h.
  • 23.
    Regimens of PE? Volumeof exchange 1-1.5 plasma volume Frequency of procedures Duration of therapy
  • 24.
    Frequancy of procedures 1-Daily plasma exchange  Most effective in rapidly depleting total body load.  Intensity of exchanges has no major effect on outcomes except in hemolytic-uremic syndrome. 2- Alternate-day exchanges  proven efficacy in antineutrophil cytoplasmic antibody (ANCA)–associated diseases.
  • 26.
     A singleplasma volume exchange will lower plasma macromolecule levels by approximately 60% .  Five exchanges during 5 to 10 days will clear 90% of the total body Immunoglobulin
  • 27.
    Target molecule kineticsduring therapeutic plasma exchange. Mark E. Williams, and Rasheed A. Balogun CJASN doi:10.2215/CJN.04680513 ©2013 by American Society of Nephrology
  • 31.